Katana Biopharma

Canada Founded: 2016 • Age: 10 yrs Acquired By Theratechnologies
Targeted oncology technology platform is developed for cancer treatment.

About Katana Biopharma

Katana Biopharma is a Healthcare company based in Canada founded in 2016, and was acquired by Theratechnologies in February 2019. Targeted oncology technology platform is developed for cancer treatment. The company was acqui-hired. Its focus areas include Life Sciences, Oncology, Drugs and Diversified.

Company details

Katana Biopharma was founded in 2016 and is based in Canada. Operations are conducted in the biotechnology sector, where a targeted oncology technology platform is developed for therapeutic applications. Focus is placed on research and development of innovative treatments for cancer. The platform enables precise delivery mechanisms, with activities centered on advancing oncology solutions through proprietary methods.

Operational Areas
Key Metrics

Investors in Katana Biopharma

Katana Biopharma has secured backing from 1 investor. Prominent investors backing the company include Theratechnologies.

All
InvestorDescriptionFounded YearDomainLocation
Drugs are developed to reduce abdominal fat from HIV treatments.
1993theratech.comMontreal, Canada
Premium access

Investor details for Katana Biopharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Katana Biopharma

2 dated milestones of Katana Biopharma across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Katana Biopharma is founded.
  2. Exit Acquired by Theratechnologies.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Katana Biopharma

Premium access

Complete news archive for Katana Biopharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Katana Biopharma

Katana Biopharma was founded in 2016.

Katana Biopharma is headquartered in Canada.

Katana Biopharma was founded in 2016 and is based in Canada. Operations are conducted in the biotechnology sector, where a targeted oncology technology platform is developed for therapeutic applications. Focus is placed on research and development of innovative treatments for cancer. The platform enables precise delivery mechanisms, with activities centered on advancing oncology solutions through proprietary methods.

Katana Biopharma has 1 investor. Key investors include Theratechnologies.

Yes. Katana Biopharma was acquired by Theratechnologies in February 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available